DR. DAVID CRAWFORD CAMPBELL, MD
Medical Practice in San Diego, CA
License number
California G25976
Category
Medical Practice
Type
Ophthalmology
Address
Address
4060 Fourth Ave SUITE 405, San Diego, CA 92103
Phone
(619) 297-9131
(619) 297-6375 (Fax)
(619) 297-6375 (Fax)
Professional information
6-(Ethynyl)Pyrido[2,3-D]Pyrimidin-7(8H)-Ones For The Treatment Of Cns Disorders
US Patent:
2013024, Sep 19, 2013
Filed:
Jun 10, 2011
Appl. No.:
13/702969
Inventors:
David Campbell - San Diego CA, US
Sergio G. Duron - San Diego CA, US
Benedikt Vollrath - San Diego CA, US
Warren Wade - San Diego CA, US
Sergio G. Duron - San Diego CA, US
Benedikt Vollrath - San Diego CA, US
Warren Wade - San Diego CA, US
Assignee:
AFRAXIS, INC. - La Jolla CA
International Classification:
C07D 471/04
US Classification:
5142342, 544279, 51425216, 544117, 435184
Abstract:
Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders.
8-(Heteroarylmethyl)Pyrido[2,3-D]Pyrimidin-7(8H)-Ones For The Treatment Of Cns Disorders
US Patent:
2013023, Sep 5, 2013
Filed:
Jun 9, 2011
Appl. No.:
13/702572
Inventors:
David Campbell - San Diego CA, US
Sergio G. Duron - San Diego CA, US
Benedikt Vollrath - San Diego CA, US
Warren Wade - San Diego CA, US
Sergio G. Duron - San Diego CA, US
Benedikt Vollrath - San Diego CA, US
Warren Wade - San Diego CA, US
Assignee:
AFRAXIS, INC. - La Jolla CA
International Classification:
C07D 471/04
US Classification:
51425216, 544279, 435184
Abstract:
Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders.
Logistics Manager At Tasc Inc.
Position:
Logistics Manager at TASC Inc.
Location:
Greater San Diego Area
Industry:
Government Relations
Work:
TASC Inc.
-
Logistics Manager
David Crawford Campbell, San Diego CA
Specialties:
Ophthalmologist
Address:
4060 4Th Ave, San Diego, CA 92103
Education:
University of Rochester, School of Medicine and Dentistry - Doctor of Medicine
UCSD Healthcare - Residency - Ophthalmology
UCSD Healthcare - Residency - Internal Medicine
UCSD Healthcare - Residency - Ophthalmology
UCSD Healthcare - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Ophthalmology Certification in Ophthalmology
Adenine Nucleotide-Binding Protein-Directed Probes, And Methods Of Their Synthesis And Use
US Patent:
2003013, Jul 17, 2003
Filed:
Aug 5, 2002
Appl. No.:
10/213359
Inventors:
David Campbell - San Diego CA, US
Paul Wash - San Diego CA, US
Paul Wash - San Diego CA, US
Assignee:
ActivX Biosciences, Inc,
International Classification:
C12Q001/68, G01N033/53
US Classification:
435/006000, 435/007100
Abstract:
The invention relates to compositions and methods for the synthesis and use of Adenosine nucleotide binding protein-directed affinity labels. Adenosine nucleotide binding proteins may be labeled with probes comprising adenosine, or an analogue thereof, functionalized at the 5′ position with reactive group capable of reacting with an amino acid side chain functionality at an adenosine nucleotide binding site, and at the 2′ or 3′ position with a TAG for sequestering and/or identifying the resulting conjugate. The probes may be used for determining the presence or amount of one or more adenosine nucleotide binding proteins in a complex mixture, particularly a cellular mixture, for screening for drugs, and other purposes associated with the presence of the adenine nucleotide-binding protein(s) in a cell or changes in the presence, amount, activity, or relative concentration of the active adenosine nucleotide-binding protein.
Methods And Intermediates For Synthesis Of Selective Dpp-Iv Inhibitors
US Patent:
2010008, Apr 8, 2010
Filed:
Mar 5, 2008
Appl. No.:
12/529016
Inventors:
David Alan Campbell - San Diego CA, US
Emília P.T. Leitão - Sao Marcos, PT
Peng Wang - Carlsbad CA, US
Emília P.T. Leitão - Sao Marcos, PT
Peng Wang - Carlsbad CA, US
Assignee:
Phenomix Corporation - San Diego CA
International Classification:
C07F 5/02, C07D 403/12, C07D 207/00
US Classification:
548405, 548518, 548531
Abstract:
Methods and intermediates for the synthesis of selective inhibitors of dipeptidyl peptidase IV (DPP-IV) are provided. Coupling of a carboxylate salt with a boro-proline derivative provides a protected form of a DPP-IV inhibitor, which may be deblocked to yield the medicinal compound. The carboxylate salt can be a crystalline form of a sodium salt or a dicyclohexylammonium salt. The inhibitor can be used in the treatment of diabetes.
Acyl-Nucleotide Probes And Methods Of Their Synthesis And Use In Proteomic Analysis
US Patent:
7365178, Apr 29, 2008
Filed:
Apr 1, 2004
Appl. No.:
10/817454
Inventors:
David Alan Campbell - San Diego CA, US
Marek Liyanage - Carlsbad CA, US
Anna Katrin Szardenings - San Diego CA, US
Min Wu - San Diego CA, US
Marek Liyanage - Carlsbad CA, US
Anna Katrin Szardenings - San Diego CA, US
Min Wu - San Diego CA, US
Assignee:
Activx Biosciences, Inc. - La Jolla CA
International Classification:
C07H 21/02, C07H 21/00, C12Q 1/68, G01N 33/53, A61K 38/00, C07K 1/00
US Classification:
536 231, 536 253, 435 6, 435 71, 530300, 530350
Abstract:
The present invention provides tagged acyl phosphate probes (“TAPPs”), and methods of their preparation and use. The subject methods and compositions can provide enhanced simplicity and accuracy in identifying changes in the presence, amount, or activity of target proteins in a complex protein mixture, preferably nucleotide binding proteins using nucleotide binding protein-directed TAPPs. The profiling methods described herein can have a number of steps leading to the identification of target nucleotide binding protein(s) in a complex protein mixture.
Methods Of Preparing Heterocyclic Boronic Acids And Derivatives Thereof
US Patent:
7786312, Aug 31, 2010
Filed:
Jul 27, 2006
Appl. No.:
11/996792
Inventors:
David Alan Campbell - San Diego CA, US
David T. Winn - San Diego CA, US
David T. Winn - San Diego CA, US
Assignee:
Phenomix Corporation - San Diego CA
International Classification:
C07F 5/02
US Classification:
548408, 548558
Abstract:
In the context of synthesizing heterocyclic boronic acid compounds, a convergent synthetic methodology is particularly efficient for preparing boropyrrolidines and derivatives of boropyrrolidines.
E N/A At E N/A
Position:
e n/a at e n/a
Location:
Greater San Diego Area
Industry:
Retail
Work:
e n/a
-
e n/a
Methods For Treating Alzheimer's Disease
US Patent:
2012027, Oct 25, 2012
Filed:
Oct 8, 2010
Appl. No.:
13/500293
Inventors:
Jay Lichter - Rancho Santa Fe CA, US
Benedikt Vollrath - San Diego CA, US
David Campbell - San Diego CA, US
Sergio G. Durón - San Diego CA, US
Benedikt Vollrath - San Diego CA, US
David Campbell - San Diego CA, US
Sergio G. Durón - San Diego CA, US
Assignee:
aFRAXis, Inc. - La Jolla CA
International Classification:
A61K 31/519, G01N 33/50, A61K 31/5377, A61K 31/506, A61K 31/65, A61P 25/28
US Classification:
514154, 51425216, 5142342, 51426411, 51425211, 51425218, 514275, 5142358, 436 86
Abstract:
Provided herein arc PAK inhibitors. Also provided herein are compositions and methods for treating an individual suffering from Alzheimer's disease.